Cargando…

Synergistic effects of 15-deoxy Δ(12,14)-prostaglandin J(2) on the anti-tumor activity of doxorubicin in renal cell carcinoma

An endogenous anticancer agent, 15-deoxy -Δ(12,14)-prostaglandin J(2) (15d-PGJ(2)) induces apoptosis in the chemoresistant renal cell carcinoma (RCC). Peroxisome proliferator-activated receptor-γ (PPARγ) is a nuclear receptor for 15d-PGJ(2), and mediates the cytotoxicity of 15d-PGJ(2) in many cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto, Yasuhiro, Yamamoto, Takehiro, Koma, Hiromi, Nishii, Ayaka, Yagami, Tatsurou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614541/ https://www.ncbi.nlm.nih.gov/pubmed/28955990 http://dx.doi.org/10.1016/j.bbrep.2016.11.004

Ejemplares similares

15-deoxy-Δ(12,14)-prostaglandin J(2) in neurodegenerative diseases and cancers
por: Yagami, Tatsurou, et al.
Publicado: (2017)

A plausible involvement of plasmalemmal voltage‐dependent anion channel 1 in the neurotoxicity of 15‐deoxy‐Δ(12,14)‐prostaglandin J(2)
por: Koma, Hiromi, et al.
Publicado: (2020)

15-deoxy-Δ(12, 14)-prostaglandin J(2) enhances anticancer activities independently of VHL status in renal cell carcinomas
por: Koma, Hiromi, et al.
Publicado: (2019)

Proteomic Identification of Protein Targets for 15-Deoxy-Δ(12,14)-Prostaglandin J(2) in Neuronal Plasma Membrane
por: Yamamoto, Yasuhiro, et al.
Publicado: (2011)

Correction: Proteomic Identification of Protein Targets for 15-Deoxy-Δ(12,14)-Prostaglandin J(2) in Neuronal Plasma Membrane
por: Yamamoto, Yasuhiro, et al.
Publicado: (2011)

Cytotoxicity of 15-Deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent Pathway and the Involvement of the JNK and Akt Pathway in Renal Cell Carcinoma
por: Fujita, Megumi, et al.
Publicado: (2012)

Feedback Control of the Arachidonate Cascade in Osteoblastic Cells by 15-deoxy-Δ(12,14)-Prostaglandin J(2)
por: Ishino, Hidetaka, et al.
Publicado: (2008)

Rac1 modification by an electrophilic 15-deoxy Δ(12,14)-prostaglandin J(2) analog
por: Wall, S.B., et al.
Publicado: (2015)

15-Deoxy-Δ(12,14) Prostaglandin J(2) Reduces the Formation of Atherosclerotic Lesions in Apolipoprotein E Knockout Mice
por: Seno, Takahiro, et al.
Publicado: (2011)

15-Deoxy-Δ(12,14)-Prostaglandin J(2) Inhibits Macrophage Colonization by Salmonella enterica Serovar Typhimurium
por: Buckner, Michelle M. C., et al.
Publicado: (2013)

15-Deoxy-△(12,14)-Prostaglandin J(2) Promotes Resolution of Experimentally Induced Colitis
por: Kim, Wonki, et al.
Publicado: (2021)

Effects of 15-Deoxy-Δ(12,14)-Prostaglandin J2 (15d-PGJ2) and Rosiglitazone on Human Vδ2(+) T Cells
por: Li, Haishan, et al.
Publicado: (2009)

15-Deoxy-Δ(12,14)-prostaglandin J(2) Induces Apoptosis and Upregulates SOCS3 in Human Thyroid Cancer Cells
por: Trindade-da-Silva, Carlos Antônio, et al.
Publicado: (2016)

15-Deoxy-Δ(12,14)-Prostaglandin J(2) Modifies Components of the Proteasome and Inhibits Inflammatory Responses in Human Endothelial Cells
por: Marcone, Simone, et al.
Publicado: (2016)

The Effects of Co-Treatment of 9-cis-Retinoic Acid and 15-Deoxy-Δ (12,14)-prostaglandin J2 on Microglial Activation
por: Hsu, Pei-Chien, et al.
Publicado: (2011)

Cytotoxic effects of 15-deoxy-Δ12,14-prostaglandin J2 alone and in combination with dasatinib against uterine sarcoma in vitro
por: Kawakita, Takako, et al.
Publicado: (2017)

15-deoxy-delta(12,14)-prostaglandin J(2 )induces apoptosis in human articular chondrocytes
por: Masuko-Hongo, K, et al.
Publicado: (2003)

15-deoxy-Δ(12,14)-Prostaglandin J(2) inhibits human soluble epoxide hydrolase by a dual orthosteric and allosteric mechanism
por: Abis, Giancarlo, et al.
Publicado: (2019)

15-Deoxy-Δ(12,14)-prostaglandin J(2) Exerts Antioxidant Effects While Exacerbating Inflammation in Mice Subjected to Ureteral Obstruction
por: Nilsson, Line, et al.
Publicado: (2017)

Changes in the Th1 : Th2 Cytokine Bias in Pregnancy and the Effects of the Anti-Inflammatory Cyclopentenone Prostaglandin 15-Deoxy-Δ(12,14)-Prostaglandin J(2)
por: Sykes, Lynne, et al.
Publicado: (2012)

Transcription of Liver X Receptor Is Down-Regulated by 15-Deoxy-Δ(12,14)-Prostaglandin J(2) through Oxidative Stress in Human Neutrophils
por: Alba, Gonzalo, et al.
Publicado: (2012)

15-Deoxy-Δ(12,14)-Prostaglandin J(2) Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss
por: Kim, Ki Rim, et al.
Publicado: (2015)

15-Deoxy-Δ(12,14)-prostaglandin J2 promotes phosphorylation of eukaryotic initiation factor 2α and activates the integrated stress response
por: Tauber, Devin, et al.
Publicado: (2019)

15-Deoxy-Δ(12,14)-prostaglandin J(2) Induces Epithelial-to-mesenchymal Transition in Human Breast Cancer Cells and Promotes Fibroblast Activation
por: Choi, Jeehye, et al.
Publicado: (2020)

15-deoxy-delta12,14-prostaglandin J2 attenuates endothelial-monocyte interaction: implication for inflammatory diseases
por: Prasad, Ratna, et al.
Publicado: (2008)

Sensitive mass spectrometric assay for determination of 15-deoxy-Δ(12,14)-prostaglandin J(2) and its application in human plasma samples of patients with diabetes
por: Morgenstern, Jakob, et al.
Publicado: (2017)

15-Deoxy-Δ(12,14)-prostaglandin J(2) inhibits migration of human thyroid carcinoma cells by disrupting focal adhesion complex and adherens junction
por: Wu, Ya-Chieh, et al.
Publicado: (2017)

STAT3 as a Potential Target for Tumor Suppressive Effects of 15-Deoxy-Δ(12,14)-prostaglandin J(2) in Triple Negative Breast Cancer
por: Kim, Su-Jung, et al.
Publicado: (2021)

15-Deoxy-Δ(12,14)-prostaglandin J(2) as a potential regulator of bone metabolism via PPARγ-dependent and independent pathways: a review
por: Xiong, Zhencheng, et al.
Publicado: (2019)

15-Deoxy-Δ(12,14)-prostaglandin J(2) Upregulates VEGF Expression via NRF2 and Heme Oxygenase-1 in Human Breast Cancer Cells
por: Kim, Eun-Hee, et al.
Publicado: (2021)

15-Deoxy-Delta-12,14-Prostaglandin J(2) Inhibits Lung Inflammation and Remodeling in Distinct Murine Models of Asthma
por: Coutinho, Diego S., et al.
Publicado: (2017)

The PPAR-γ Agonist 15-Deoxy-Δ (12,14)-Prostaglandin J(2) Attenuates Microglial Production of IL-12 Family Cytokines: Potential Relevance to Alzheimer's Disease
por: Xu, Jihong, et al.
Publicado: (2008)

The Eicosapentaenoic Acid Metabolite 15-Deoxy-δ(12,14)-Prostaglandin J(3) Increases Adiponectin Secretion by Adipocytes Partly via a PPARγ-Dependent Mechanism
por: Lefils-Lacourtablaise, Jennifer, et al.
Publicado: (2013)

15-Deoxy-∆-(12,14)-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism
por: Li, Jingjing, et al.
Publicado: (2019)

Effect of 15-Deoxy-∆(12,14)-prostaglandin J(2) Nanocapsules on Inflammation and Bone Regeneration in a Rat Bone Defect Model
por: Tang, Qi, et al.
Publicado: (2017)

15-Deoxy-Δ(12,14)-ProstaglandinJ2 Regulates Dedifferentiation through Peroxisome Proliferator-Activated Receptor-γ-Dependent Pathway but Not COX-2 Expression in Articular Chondrocytes
por: Lee, Ji-Hye, et al.
Publicado: (2007)

15-Deoxy-Δ(12,14)-Prostaglandin J(2) Inhibits Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury via Redox Pathway
por: Liu, Xin, et al.
Publicado: (2015)

Topical Administration of 15-Deoxy-Δ(12,14)-Prostaglandin J(2) Using a Nonionic Cream: Effect on UVB-Induced Skin Oxidative, Inflammatory, and Histopathological Modifications in Mice
por: Kumagai, Clovis M., et al.
Publicado: (2021)

Interleukin-6 Synthesis in Human Chondrocytes Is Regulated via the Antagonistic Actions of Prostaglandin (PG)E(2) and 15-deoxy-Δ(12,14)-PGJ(2)
por: Wang, Pu, et al.
Publicado: (2011)

Damage-associated molecular pattern (DAMP) activation in melanoma: investigation of the immunogenic activity of 15-deoxy, Δ(12,14) prostamide J(2)
por: Elhassanny, Ahmed, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ua9kk6sl94u59gtkvsqn0aqjgc